General Notices

• Notice of Availability: Draft Scientific Integrity Policy of the National Institutes of Health
  (NOT-OD-23-183)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of FY2024 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
  (NOT-OD-23-188)
  Office of the Director, NIH
  

Funding Opportunities

• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
  (PAR-23-301)
  National Human Genome Research Institute
  Application Receipt Date(s): January 07, 2027
  
  

• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
  (PAR-23-302)
  National Human Genome Research Institute
  Application Receipt Date(s): January 07, 2027
  
  

• Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
  (PAR-23-309)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): November 05, 2026
  
  

• Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
  (RFA-MD-24-003)
  National Institute on Minority Health and Health Disparities
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
  (RFA-NS-23-032)
  National Institute of Neurological Disorders and Stroke
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 28, 2023